Trending News

US Tariff and Trade Update: Temporary Pause on Canada and Mexico, Tariffs on China, China Retaliation, and What's Next

Tariffs Paused in Mexico and Canada, but not China

Funding Freeze for Health Care Providers – What You Need to Know

FTC Announces Updates to COPPA Rule

Video Game Maker to Pay $20 Million to Settle FTC COPPA Enforcement Action

FTC Announces New HSR Notification Thresholds for 2025

Ceramtec GMBH v. Coorstek Biocermanics LLC

FTC Finalizes Long-Awaited Updates to Children's Privacy Rule

FTC Finalizes Changes to Children's Privacy Rule

DOE Announces Intent to Fund R&D to Advance Biofuels and Bioproducts

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Sixty Degrees Pharmaceuticals to Ensure Continuity of Tafenoquine Supply in U.S. by Importing Limited Quantity of KODATEF®
Posted On Tuesday, February 11, 2025
Titan Partners Announces Launch of Equity Research Division, Appoints Boris Peaker as Senior Healthcare Analyst
Posted On Tuesday, February 11, 2025
Creative Medical Technology Reports Positive One-Year Results for AlloStem™ Type 2 Diabetes Program
Posted On Tuesday, February 11, 2025
BEYONTTRA™ (acoramidis), the First Near Complete TTR Stabilizer (≥90%), Approved by the European Commission to Treat ATTR-CM
Posted On Tuesday, February 11, 2025
Tiziana Life Sciences Announces TV Interview with First Patient Dosed with Moderate Alzheimer’s Disease
Posted On Tuesday, February 11, 2025
Artelo Biosciences to Present its New Data on ART12.11 Tablets Compared to Epidiolex at the IMCCB-25 Conference in Bern, Switzerland
Posted On Tuesday, February 11, 2025
Nutriband Inc. Announces Olympian Anastasia Nichita to Advisory Board
Posted On Tuesday, February 11, 2025
PathAI and Rede D’Or Announce Strategic Partnership to Bring AI-Powered Pathology Solutions to Brazil
Posted On Tuesday, February 11, 2025
Metagenomi to Present at TD Cowen's 45th Annual Health Care Conference
Posted On Tuesday, February 11, 2025
AIM ImmunoTech Releases Virtual Investor “What This Means Segment”
Posted On Tuesday, February 11, 2025
LIXTE Biotechnology Announces $1.05 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Posted On Tuesday, February 11, 2025
Oncocyte to Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Posted On Tuesday, February 11, 2025
AIM ImmunoTech announces that it will not proceed with an offering pursuant to its Registration Statement on Form S-1 until after it files its Annual Report on Form 10-K for the fiscal year ended December 31, 2024
Posted On Tuesday, February 11, 2025
Alkeus Pharmaceuticals Announces Two Presentations of Oral Gildeuretinol Data During the 48th Annual Meeting of the Macula Society Being Held February 12-15, 2025
Posted On Tuesday, February 11, 2025
LB Pharmaceuticals Announces Key Executive Appointments to Support Growth and Late-Stage Development of LB-102
Posted On Tuesday, February 11, 2025
Oragenics, Inc. Announces Partnership with BRAINBox Solutions to Revolutionize Concussion Diagnosis and Treatment
Posted On Tuesday, February 11, 2025
Day One to Report Fourth Quarter and Full-Year 2024 Financial Results Tuesday, February 25, 2025
Posted On Tuesday, February 11, 2025
Achieve Life Sciences to Present at the Oppenheimer Healthcare Life Sciences Conference
Posted On Tuesday, February 11, 2025
3Daughters Announces Appointment of John Poulos to the Board of Directors
Posted On Tuesday, February 11, 2025
Ampersand Biomedicines Appoints Elizabeth Mily to Board of Directors
Posted On Tuesday, February 11, 2025
EvolveImmune Appoints Kristen M. Hege, M.D. to Its Board of Directors
Posted On Tuesday, February 11, 2025
Chicago Biomedical Consortium to Serve as Regional Host Committee Chair for BioCentury’s Grand Rounds - U.S. Conference
Posted On Tuesday, February 11, 2025
Cytokinetics Names Robert E. Landry to Board of Directors
Posted On Tuesday, February 11, 2025
Bind Research launched to transform disordered proteins into effective drug targets
Posted On Tuesday, February 11, 2025
Tevogen Bio's Business Model Addresses Biopharma Industry Challenges with Cost-Efficient Innovation
Posted On Tuesday, February 11, 2025

Print